메뉴 건너뛰기




Volumn 98, Issue 8, 2008, Pages 614-617

Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; GLUTATHIONE PEROXIDASE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; LIPID PEROXIDE; SUPEROXIDE DISMUTASE; 8-HYDROXY-2'-DEOXYGUANOSINE; DEOXYGUANOSINE; DRUG DERIVATIVE;

EID: 55949086962     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (53)

References (16)
  • 1
    • 0002219891 scopus 로고    scopus 로고
    • What is oxidative stress?
    • Keaney JF Jr, ed, Boston: Kluwer Academic Publishers
    • Sies H. What is oxidative stress? In: Keaney JF Jr, ed. Oxidative Stress and Vascular Disease. Boston: Kluwer Academic Publishers, 2000: 1-8.
    • (2000) Oxidative Stress and Vascular Disease , pp. 1-8
    • Sies, H.1
  • 2
    • 0039483044 scopus 로고    scopus 로고
    • Changes in antioxidant status of heart muscle tissue in experimental diabetes in rabbits
    • Gumieniczek A, Hopkala H, Wojtowich Z, Nikolajuk J. Changes in antioxidant status of heart muscle tissue in experimental diabetes in rabbits. Acta Biochim Pol 2002; 49: 529-535.
    • (2002) Acta Biochim Pol , vol.49 , pp. 529-535
    • Gumieniczek, A.1    Hopkala, H.2    Wojtowich, Z.3    Nikolajuk, J.4
  • 4
    • 0033951258 scopus 로고    scopus 로고
    • What is oxidative stress?
    • Betteridge DJ. What is oxidative stress? Metabolism 2000; 49: 3-8.
    • (2000) Metabolism , vol.49 , pp. 3-8
    • Betteridge, D.J.1
  • 6
    • 0030948596 scopus 로고    scopus 로고
    • Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by monoclonal N45.1, its application to ferric nitrilotriacetate-induced renal carcinogenesis model
    • Toyokuni S, Tanaka T, Hattori Y, et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by monoclonal N45.1, its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76(3): 365-374.
    • (1997) Lab Invest , vol.76 , Issue.3 , pp. 365-374
    • Toyokuni, S.1    Tanaka, T.2    Hattori, Y.3
  • 7
    • 0021948587 scopus 로고
    • Superoxide dismutase and glutathione peroxidase activities in neutrophils from selenium deficient and copper deficient cattle
    • Arthur JR, Boyne R. Superoxide dismutase and glutathione peroxidase activities in neutrophils from selenium deficient and copper deficient cattle. Life Sci 1985; 36: 1569-1575.
    • (1985) Life Sci , vol.36 , pp. 1569-1575
    • Arthur, J.R.1    Boyne, R.2
  • 8
    • 0014108436 scopus 로고
    • Glutathione peroxidase determination
    • Paglia DE, Valentine WN. Glutathione peroxidase determination. J Lab Clin Med 1967; 70: 158-169.
    • (1967) J Lab Clin Med , vol.70 , pp. 158-169
    • Paglia, D.E.1    Valentine, W.N.2
  • 9
    • 0141884341 scopus 로고    scopus 로고
    • Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy
    • Bhatia S, Shukla R, Madhu SV, Gambhir JK, Prabhu KM. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 2003; 36(7): 557-562.
    • (2003) Clin Biochem , vol.36 , Issue.7 , pp. 557-562
    • Bhatia, S.1    Shukla, R.2    Madhu, S.V.3    Gambhir, J.K.4    Prabhu, K.M.5
  • 10
    • 0032756560 scopus 로고    scopus 로고
    • B-carotene affects antioxidant status in non-insulin-dependent diabetes mellitus
    • Levy U, Zaltzber H, Ben-Amotz A, Kanter Y, Aviram M. B-carotene affects antioxidant status in non-insulin-dependent diabetes mellitus. Pathophysiol 1999; 6: 157-161.
    • (1999) Pathophysiol , vol.6 , pp. 157-161
    • Levy, U.1    Zaltzber, H.2    Ben-Amotz, A.3    Kanter, Y.4    Aviram, M.5
  • 11
    • 0030726212 scopus 로고    scopus 로고
    • Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM
    • Santini SA, Marra G, Giardina B, et al. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 1997; 46(11): 1853-1858.
    • (1997) Diabetes , vol.46 , Issue.11 , pp. 1853-1858
    • Santini, S.A.1    Marra, G.2    Giardina, B.3
  • 12
    • 0030039242 scopus 로고    scopus 로고
    • Oxidative damage to DNA in diabetes mellitus
    • Dandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996; 347(8999): 444-445.
    • (1996) Lancet , vol.347 , Issue.8999 , pp. 444-445
    • Dandona, P.1    Thusu, K.2    Cook, S.3
  • 13
    • 0032012114 scopus 로고    scopus 로고
    • Use of antioxidants in the prevention and treatment of disease
    • Kelly FJ. Use of antioxidants in the prevention and treatment of disease. J Int Fed Clin Chem 1998; 10(1): 21-23.
    • (1998) J Int Fed Clin Chem , vol.10 , Issue.1 , pp. 21-23
    • Kelly, F.J.1
  • 14
    • 0035113190 scopus 로고    scopus 로고
    • Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: Effects of glycemic control
    • Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin Biochem 2001; 34: 65-70.
    • (2001) Clin Biochem , vol.34 , pp. 65-70
    • Aydin, A.1    Orhan, H.2    Sayal, A.3    Ozata, M.4    Sahin, G.5    Isimer, A.6
  • 15
    • 0033675481 scopus 로고    scopus 로고
    • Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications
    • Kesavulu MM, Giri R, Kameswara RB, Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 2000; 26(5): 387-392.
    • (2000) Diabetes Metab , vol.26 , Issue.5 , pp. 387-392
    • Kesavulu, M.M.1    Giri, R.2    Kameswara, R.B.3    Apparao, C.4
  • 16
    • 18744372726 scopus 로고    scopus 로고
    • Lipid peroxidation and antioxidant status in patients with diabetic retinopathy
    • Gupta MM, Chari S. Lipid peroxidation and antioxidant status in patients with diabetic retinopathy. Ind J Physiol Pharmacol 2005; 49(2): 187-192.
    • (2005) Ind J Physiol Pharmacol , vol.49 , Issue.2 , pp. 187-192
    • Gupta, M.M.1    Chari, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.